Dr. Kipps descriptions of chemokines being like our nose being drawn to a Thanksgiving dinner is an analogy that even a vegan can love.
My blog: bkoffman.blogspot.com has the second segment of the ASH2012 interview, mostly on the new BCR inhibitors
ASH 2012, Dr Kipps on BCR inhibitors - CLL Support
ASH 2012, Dr Kipps on BCR inhibitors
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
2 Replies
•
Hi keep the videos coming as they offer an insight to whats new. Best wishes
bkoffmanCLL CURE Hero
I just published part 3 which is a wide ranging section of the interview covering antibodies, CAR-T, old drugs repurposed, and more. Kipps is an excellent teacher. See: bkoffman.blogspot.com
Not what you're looking for?
You may also like...
ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance
Venetoclax was changed how we treat CLL, but it doesn't work for everyone and it doesn't always...
ASH 2016: Dr. Mato on real world data on ibrutinib
Hi,
This week I'm posting an interview that I had with Dr. Anthony Mato from U Penn when we talked...
ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"
Dr Sharman's blog http://www.cll-nhl.com, is well worth keeping an eye on for pertinent but easily...
ASH 2016: Dr. Seymour on Combination therapies with venetoclax
Hi,
I am a big believer in combination therapies for CLL.
This week I'm posting an interview on our...
Related Posts
- Patient Power interviews Dr Michael Keating at ASH 2012. FCR and the transition to better, kinder treatments.
- ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL
- ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB
Reflections on my New Year's Eve, 2012- ASH 2014. Dr. Sharman discusses the biology of our CLL cells
